Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07635641
Recruiting
REPROton-HN: Prospective Observational Study on Proton Re-irradiation for Locoregional Recurrences of Head and Neck Tumors
Not applicable · Italy · 1 site
Registry update: 9 Jun 2026
NCT07574593
Recruiting
NORM-HF Pivotal Study
Not applicable · United States · 25 sites
Registry update: 16 Oct 2026
NCT07615985
Recruiting
Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016
Phase 1 · Australia · 1 site
Registry update: 23 Sept 2026
NCT07683468
Recruiting
Study on the Self-Administered Use of a Specialized Kit for the Management of Sexual Pain Associated With Endometriosis
Not applicable · France · 1 site
Registry update: 6 Jul 2026
NCT07619313
Recruiting
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Phase 1 · United States · 1 site
Registry update: 20 Aug 2026
NCT07594652
Recruiting
Medication Treatment of ADHD in Pediatric Epilepsy
Phase 4 · United States · 1 site
Registry update: 29 Jul 2026
2025-523396-38-00
Recruiting
Multi-centre Phase 1/2 study testing LB-208 for adults with relapsed/refractory AML or high-risk MDS
Phase 1/2 · Spain · 6 sites
Registry update: 9 Oct 2026
NCT06955260
Recruiting
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
Phase 3 · Canada · 2 sites
Registry update: 2 Sept 2026
NCT07480356
Recruiting
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Phase 3 · Ukraine, United States · 11 sites
Registry update: 6 Oct 2026
NCT07559396
Recruiting
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
Phase 1 · United States · 2 sites
Registry update: 16 Jun 2026
NCT07886047
Recruiting
Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer
Phase 1 · China · 4 sites
Registry update: 21 Oct 2026
NCT07478848
Recruiting
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
Phase 1 · United States · 1 site
Registry update: 1 Jul 2026
NCT07528027
Recruiting
Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity
Phase 3 · China · 2 sites
Registry update: 24 Sept 2026
NCT07271966
Recruiting
B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy
Not applicable · United States · 1 site
Registry update: 29 Jul 2026
NCT07101328
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Phase 1 · Australia, Canada, Germany, Denmark, Spain, France, United Kingdom, Italy, Japan, South Korea, Poland, United States · 51 sites
Registry update: 4 Nov 2026
NCT07623668
Recruiting
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Phase 3 · United States · 4 sites
Registry update: 14 Aug 2026
NCT07608848
Recruiting
First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer
Early phase 1 · Australia · 1 site
Registry update: 10 Jun 2026
NCT06930508
Recruiting
Bringing Medicines for HIV Prevention to a Family Planning Clinic
Not applicable · United States · 1 site
Registry update: 6 Aug 2026
2025-521590-13-00
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Phase 3 · Austria, Belgium, Czechia, Germany, Denmark, Spain, France, Hungary, Italy, Netherlands, Poland, Sweden, Slovakia · 105 sites
Registry update: 28 Aug 2026
NCT07635238
Recruiting
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
Phase 2 · United States · 7 sites
Registry update: 18 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.